![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Goldberger J.J. Neelagaru S.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.9, Iss.11, 2000-11, pp. : 2543-2554
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Risk of sudden cardiac death with commonly prescribed drugs
Reactions Weekly, Vol. 1, Iss. 1052, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Calstabin2 – a new target in sudden cardiac death
Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 6, 2004-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Quetiapine overdose: Sudden cardiac death: case report
Reactions Weekly, Vol. 1, Iss. 1431, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Complex Inheritance for Susceptibility to Sudden Cardiac Death
Current Pharmaceutical Design, Vol. 19, Iss. 39, 2013-12 ,pp. :